# OnCo record paper-intuitt-nf2-brigatinib-plotkin-nejm-2024 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-intuitt-nf2-brigatinib-plotkin-nejm-2024/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-intuitt-nf2-brigatinib-plotkin-nejm-2024" ;
  schema:name "INTUITT-NF2: brigatinib in NF2-related schwannomatosis with progressive tumours"@en ;
  schema:description "In people with the inherited condition NF2 whose nerve and brain-lining tumours were growing despite earlier treatment, the kinase inhibitor brigatinib shrank some tumours, slowed the growth of all types and improved hearing in a third of affected ears without serious toxicity."@en ;
  schema:url <https://onco.cc/key-papers/paper-intuitt-nf2-brigatinib-plotkin-nejm-2024/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa2400985>, <https://pubmed.ncbi.nlm.nih.gov/38904277/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa2400985> ;
  schema:datePublished "2024"^^xsd:gYear ;
  schema:author "Plotkin SR, Yohay KH, Nghiemphu PL, et al." ;
  onco:cancers <https://onco.cc/cancers/vestibular-schwannoma/>, <https://onco.cc/cancers/meningioma/> ;
  onco:drugs <https://onco.cc/drugs/brigatinib/> ;
  onco:trials <https://onco.cc/trials/intuitt-nf2/> ;
  onco:journals <https://onco.cc/journals/nejm/> .